StockNews.com started coverage on shares of 22nd Century Group (NASDAQ:XXII – Free Report) in a research report sent to investors on Tuesday. The firm issued a sell rating on the biotechnology company’s stock.
22nd Century Group Stock Performance
NASDAQ XXII opened at $0.10 on Tuesday. The company has a 50-day simple moving average of $0.16 and a two-hundred day simple moving average of $0.58. 22nd Century Group has a 12-month low of $0.08 and a 12-month high of $5.28. The firm has a market cap of $4.59 million, a price-to-earnings ratio of 0.00 and a beta of 1.45. The company has a quick ratio of 0.93, a current ratio of 1.09 and a debt-to-equity ratio of 1.59.
22nd Century Group (NASDAQ:XXII – Get Free Report) last issued its earnings results on Tuesday, November 12th. The biotechnology company reported ($0.54) earnings per share for the quarter. 22nd Century Group had a negative net margin of 144.09% and a negative return on equity of 380.39%. The company had revenue of $5.95 million for the quarter.
Institutional Investors Weigh In On 22nd Century Group
22nd Century Group Company Profile
22nd Century Group, Inc, a tobacco products company, engages in the sale and distribution of its own proprietary new reduced nicotine tobacco products. The company offers reduced nicotine content tobacco plants and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands.
Read More
- Five stocks we like better than 22nd Century Group
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.